systemic necrotizing vasculitis

From Aaushi
Jump to navigation Jump to search

Management

More specific terms

Additional terms

References

  1. Coblyn JS Lower-Dose Therapy Is Associated with Fewer Serious Adverse Events in Elders with Systemic Necrotizing Vasculitis. NEJM Journal Watch. May 5, 2015 Massachusetts Medical Society (subscription needed) http://www.jwatch.org
    Pagnoux C, Quemeneur T, Ninet J et al Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: Results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy. Arthritis & rheumatology 2015 Apr; 67:1117. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25693055